MINOXIDIL FOAM 5% (WOMENS)

MINOXIDIL FOAM 5% (WOMENS) was reported 33385 times

These side effects are most commonly reported by patients taking MINOXIDIL FOAM 5% (WOMENS):

# Side effect Count
0 ADVERSE DRUG REACTION 8609
1 DRUG INEFFECTIVE 6284
2 APPLICATION SITE PRURITUS 2580
3 OFF LABEL USE 1459
4 APPLICATION SITE IRRITATION 1250
5 APPLICATION SITE PAIN 1109
6 HEADACHE 1103
7 ALOPECIA 907
8 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 781
9 APPLICATION SITE DRYNESS 746
10 CONDITION AGGRAVATED 736
11 PRODUCT ADMINISTERED AT INAPPROPRIATE SITE 674
12 RASH 668
13 DIZZINESS 640
14 HYPERSENSITIVITY 613
15 APPLICATION SITE ERYTHEMA 603
16 APPLICATION SITE EXFOLIATION 544
17 DANDRUFF 475
18 APPLICATION SITE RASH 434
19 INCORRECT DOSE ADMINISTERED 431
20 PRURITUS 424
21 NAUSEA 399
22 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 387
23 HAIR TEXTURE ABNORMAL 385
24 DYSPNOEA 379
25 FATIGUE 377
26 EXPIRED PRODUCT ADMINISTERED 336
27 PALPITATIONS 319
28 CHRONIC KIDNEY DISEASE 316
29 ANXIETY 315
30 CHEST PAIN 298
31 HYPERTENSION 287
32 HYPERTRICHOSIS 286
33 DEPRESSION 284
34 RENAL FAILURE 282
35 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 263
36 WEIGHT INCREASED 263
37 HAIR COLOUR CHANGES 262
38 PAIN 259
39 DIARRHOEA 254
40 PRODUCT USE ISSUE 247
41 HEART RATE INCREASED 237
42 ACUTE KIDNEY INJURY 234
43 VOMITING 231
44 ACCIDENTAL EXPOSURE TO PRODUCT 226
45 ERECTILE DYSFUNCTION 218
46 APPLICATION SITE SCAB 212
47 DRY SKIN 210
48 END STAGE RENAL DISEASE 205
49 SKIN EXFOLIATION 201
50 SWELLING FACE 201
51 UNDERDOSE 200
52 INSOMNIA 197
53 ARTHRALGIA 193
54 ERYTHEMA 192
55 HYPOTENSION 192
56 ASTHENIA 184
57 PRODUCT USE IN UNAPPROVED INDICATION 181
58 BLOOD PRESSURE INCREASED 180
59 PERIPHERAL SWELLING 173
60 MALAISE 170
61 OEDEMA PERIPHERAL 165
62 APPLICATION SITE PAPULES 160
63 URTICARIA 155
64 PRODUCT DOSE OMISSION ISSUE 152
65 DRUG ADMINISTERED AT INAPPROPRIATE SITE 146
66 NO ADVERSE EVENT 142
67 PERICARDIAL EFFUSION 142
68 PARAESTHESIA 139
69 VISION BLURRED 138
70 FEELING ABNORMAL 136
71 APPLICATION SITE ULCER 134
72 HYPOAESTHESIA 134
73 OVERDOSE 133
74 COUGH 132
75 CARDIAC FAILURE CONGESTIVE 130
76 SKIN IRRITATION 128
77 HAIR GROWTH ABNORMAL 126
78 PNEUMONIA 124
79 WEIGHT DECREASED 124
80 ACNE 123
81 APPLICATION SITE VESICLES 116
82 DEATH 115
83 LIBIDO DECREASED 114
84 SEXUAL DYSFUNCTION 113
85 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 111
86 ABDOMINAL PAIN 110
87 CHEST DISCOMFORT 108
88 PYREXIA 108
89 TACHYCARDIA 108
90 APPLICATION SITE ACNE 106
91 EYE IRRITATION 106
92 BACK PAIN 105
93 SWELLING 104
94 PAIN IN EXTREMITY 103
95 MYALGIA 102
96 ATRIAL FIBRILLATION 101
97 MIGRAINE 101
98 EYE SWELLING 98
99 ANAEMIA 96
100 CONSTIPATION 96
101 MYOCARDIAL INFARCTION 96
102 THERAPEUTIC PRODUCT EFFECT DECREASED 95
103 APPLICATION SITE BURN 93
104 FALL 92
105 NEPHROGENIC ANAEMIA 92
106 LOSS OF LIBIDO 87
107 PSORIASIS 87
108 CEREBROVASCULAR ACCIDENT 86
109 DECREASED APPETITE 86
110 GASTROOESOPHAGEAL REFLUX DISEASE 86
111 CONFUSIONAL STATE 85
112 COVID-19 85
113 DRUG HYPERSENSITIVITY 85
114 SOMNOLENCE 85
115 APPLICATION SITE REACTION 83
116 HAEMOGLOBIN DECREASED 83
117 URINARY TRACT INFECTION 83
118 ABDOMINAL PAIN UPPER 82
119 INTENTIONAL PRODUCT USE ISSUE 82
120 SUICIDAL IDEATION 82
121 JOINT SWELLING 81
122 RENAL INJURY 81
123 SKIN BURNING SENSATION 81
124 PLEURAL EFFUSION 79
125 CARDIAC DISORDER 78
126 RENAL IMPAIRMENT 74
127 HYPERPARATHYROIDISM SECONDARY 71
128 VERTIGO 71
129 MUSCLE SPASMS 70
130 PRODUCT FORMULATION ISSUE 70
131 VISUAL IMPAIRMENT 70
132 BLOOD CREATININE INCREASED 69
133 BURNING SENSATION 69
134 ABDOMINAL DISTENSION 67
135 HYPERHIDROSIS 67
136 SEBORRHOEA 67
137 SYNCOPE 67
138 TREMOR 67
139 EMOTIONAL DISTRESS 66
140 GAIT DISTURBANCE 66
141 INJECTION SITE PAIN 66
142 OEDEMA 66
143 APPLICATION SITE DISCOMFORT 64
144 ECZEMA 63
145 BLOOD PRESSURE DECREASED 62
146 ADVERSE EVENT 61
147 MUSCULAR WEAKNESS 61
148 APPLICATION SITE PARAESTHESIA 60
149 INFECTION 60
150 APPLICATION SITE INFLAMMATION 59
151 PULMONARY OEDEMA 59
152 TRICHORRHEXIS 59
153 BLISTER 58
154 FLUID RETENTION 58
155 SKIN DISCOLOURATION 58
156 TESTICULAR PAIN 58
157 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 58
158 ABDOMINAL DISCOMFORT 54
159 APPLICATION SITE HAEMORRHAGE 54
160 BRAIN FOG 54
161 ARRHYTHMIA 53
162 BLOOD GLUCOSE INCREASED 53
163 DEPRESSED MOOD 52
164 GENERAL PHYSICAL HEALTH DETERIORATION 52
165 HOSPITALISATION 52
166 EXPOSURE VIA SKIN CONTACT 51
167 STRESS 51
168 COMPLETED SUICIDE 50
169 DRUG EFFECT DECREASED 50
170 MEMORY IMPAIRMENT 50
171 DRUG INTERACTION 49
172 DYSGEUSIA 49
173 FLUSHING 49
174 LOSS OF CONSCIOUSNESS 49
175 PANIC ATTACK 49
176 SKIN DISORDER 49
177 BLOOD POTASSIUM INCREASED 48
178 DRUG EFFECT LESS THAN EXPECTED 48
179 NASOPHARYNGITIS 48
180 RESTLESS LEGS SYNDROME 48
181 BLOOD PRESSURE FLUCTUATION 47
182 DEHYDRATION 47
183 ILLNESS 47
184 MEDICATION ERROR 47
185 RASH PAPULAR 47
186 DYSPEPSIA 46
187 EYE PAIN 46
188 HYPERKALAEMIA 46
189 NASAL CONGESTION 46
190 TOXICITY TO VARIOUS AGENTS 46
191 ACUTE MYOCARDIAL INFARCTION 45
192 ANHEDONIA 45
193 CHILLS 45
194 HEART RATE IRREGULAR 45
195 PRESYNCOPE 45
196 SEPSIS 45
197 SWELLING OF EYELID 45
198 HAEMORRHAGE 44
199 RESTLESSNESS 44
200 THROMBOSIS 44
201 BRADYCARDIA 43
202 CARDIO-RESPIRATORY ARREST 43
203 DISCOMFORT 43
204 NEPHROGENIC SYSTEMIC FIBROSIS 43
205 OROPHARYNGEAL PAIN 43
206 ANGINA PECTORIS 42
207 GASTROINTESTINAL HAEMORRHAGE 42
208 INTENTIONAL PRODUCT MISUSE 42
209 LETHARGY 42
210 PRODUCT ADMINISTRATION ERROR 42
211 SINUSITIS 42
212 SLEEP DISORDER 42
213 HAEMORRHOIDS 41
214 NECK PAIN 41
215 SPEECH DISORDER 41
216 TINNITUS 41
217 LEFT VENTRICULAR HYPERTROPHY 40
218 APPLICATION SITE SWELLING 39
219 DERMATITIS ATOPIC 39
220 DRY EYE 39
221 HYPERTENSIVE CRISIS 39
222 PULMONARY HYPERTENSION 39
223 CONTUSION 38
224 DERMATITIS CONTACT 38
225 METABOLIC ACIDOSIS 38
226 NEUROPATHY PERIPHERAL 38
227 OCULAR HYPERAEMIA 38
228 PERIORBITAL SWELLING 38
229 SCAB 38
230 ACCIDENTAL OVERDOSE 37
231 APPLICATION SITE DISCHARGE 37
232 ASTHMA 37
233 FLUID OVERLOAD 37
234 HOT FLUSH 37
235 INJURY 37
236 UNEVALUABLE EVENT 37
237 WHITE BLOOD CELL COUNT DECREASED 37
238 APPLICATION SITE DISCOLOURATION 36
239 CARDIAC ARREST 36
240 DRY MOUTH 36
241 GASTROINTESTINAL DISORDER 36
242 CARDIAC FAILURE 35
243 CONVULSION 35
244 EPISTAXIS 35
245 FEAR 35
246 INCORRECT DRUG ADMINISTRATION DURATION 35
247 IRRITABILITY 35
248 RED BLOOD CELL COUNT DECREASED 35
249 RENAL FAILURE ACUTE 35
250 SKIN REACTION 35
251 BRONCHITIS 34
252 CARDIAC TAMPONADE 34
253 COGNITIVE DISORDER 34
254 EAR SWELLING 34
255 MOBILITY DECREASED 34
256 DERMATITIS 33
257 DYSPNOEA EXERTIONAL 33
258 RESPIRATORY FAILURE 33
259 THERAPEUTIC RESPONSE DECREASED 33
260 AGITATION 32
261 CENTRAL SEROUS CHORIORETINOPATHY 32
262 GYNAECOMASTIA 32
263 PRODUCT QUALITY ISSUE 32
264 RASH ERYTHEMATOUS 32
265 AMNESIA 31
266 BLINDNESS 31
267 CORONARY ARTERY DISEASE 31
268 DISEASE RECURRENCE 31
269 INCORRECT PRODUCT ADMINISTRATION DURATION 31
270 INJECTION SITE ERYTHEMA 31
271 PAPULE 31
272 PROTEINURIA 31
273 RENAL DISORDER 31
274 RHINORRHOEA 31
275 SKIN WRINKLING 31
276 TREATMENT NONCOMPLIANCE 31
277 ARTERIOSCLEROSIS 30
278 BASAL CELL CARCINOMA 30
279 DISTURBANCE IN ATTENTION 30
280 DYSURIA 30
281 HEPATIC STEATOSIS 30
282 MUSCULOSKELETAL STIFFNESS 30
283 SURGERY 30
284 THERAPEUTIC RESPONSE UNEXPECTED 30
285 AGGRESSION 29
286 DIABETES MELLITUS 29
287 DIALYSIS 29
288 MOOD ALTERED 29
289 PULMONARY EMBOLISM 29
290 APPLICATION SITE HYPERSENSITIVITY 28
291 BALANCE DISORDER 28
292 CONTRAINDICATED PRODUCT ADMINISTERED 28
293 FEELING HOT 28
294 FLATULENCE 28
295 INFLUENZA 28
296 NIGHT SWEATS 28
297 RASH PRURITIC 28
298 RENAL CYST 28
299 SPINAL OSTEOARTHRITIS 28
300 THROMBOCYTOPENIA 28
301 CEREBRAL INFARCTION 27
302 DRUG DOSE OMISSION 27
303 DYSPHAGIA 27
304 EYE PRURITUS 27
305 HAEMATOCRIT DECREASED 27
306 LARGE INTESTINE POLYP 27
307 LIP SWELLING 27
308 MENTAL IMPAIRMENT 27
309 RENAL FAILURE CHRONIC 27
310 STOMATITIS 27
311 THERAPEUTIC PRODUCT EFFECT DELAYED 27
312 ACTINIC KERATOSIS 26
313 ANGIOEDEMA 26
314 ARTHRITIS 26
315 BLOOD PRESSURE ABNORMAL 26
316 DRUG EFFECTIVE FOR UNAPPROVED INDICATION 26
317 HAIR INJURY 26
318 MOOD SWINGS 26
319 TARDIVE DYSKINESIA 26
320 THERAPY CESSATION 26
321 AORTIC VALVE INCOMPETENCE 25
322 BENIGN PROSTATIC HYPERPLASIA 25
323 C-REACTIVE PROTEIN INCREASED 25
324 DYSARTHRIA 25
325 GLYCOSYLATED HAEMOGLOBIN INCREASED 25
326 LACRIMATION INCREASED 25
327 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 25
328 NERVOUSNESS 25
329 PERIORBITAL OEDEMA 25
330 PLATELET COUNT DECREASED 25
331 PRODUCT PRESCRIBING ERROR 25
332 RENAL ARTERY STENOSIS 25
333 SKIN TIGHTNESS 25
334 SKIN ULCER 25
335 SWOLLEN TONGUE 25
336 ALANINE AMINOTRANSFERASE INCREASED 24
337 ASCITES 24
338 DISEASE PROGRESSION 24
339 HEPATIC ENZYME INCREASED 24
340 INJECTION SITE BRUISING 24
341 OLIGURIA 24
342 OXYGEN SATURATION DECREASED 24
343 PENIS DISORDER 24
344 PRODUCTIVE COUGH 24
345 RENAL CYST HAEMORRHAGE 24
346 TREATMENT FAILURE 24
347 UPPER RESPIRATORY TRACT INFECTION 24
348 AORTIC ARTERIOSCLEROSIS 23
349 AORTIC DILATATION 23
350 BLOOD TESTOSTERONE DECREASED 23
351 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 23
352 COMPLICATIONS OF TRANSPLANTED KIDNEY 23
353 ECONOMIC PROBLEM 23
354 FACE OEDEMA 23
355 INJECTION SITE SWELLING 23
356 MEAN CELL VOLUME INCREASED 23
357 PRODUCT MONITORING ERROR 23
358 PRODUCT SUBSTITUTION ISSUE 23
359 SPINAL STENOSIS 23
360 SQUAMOUS CELL CARCINOMA OF SKIN 23
361 TUBULOINTERSTITIAL NEPHRITIS 23
362 ACTIVATED PARTIAL THROMBOPLASTIN TIME PROLONGED 22
363 BLADDER TRANSITIONAL CELL CARCINOMA 22
364 CAROTID ARTERIOSCLEROSIS 22
365 DELAYED GRAFT FUNCTION 22
366 DIVERTICULUM INTESTINAL 22
367 FUNGAL INFECTION 22
368 GENERALISED OEDEMA 22
369 HEPATOSPLENOMEGALY 22
370 HYPOGLYCAEMIA 22
371 MENTAL STATUS CHANGES 22
372 MUSCULOSKELETAL PAIN 22
373 POLLAKIURIA 22
374 RASH MACULAR 22
375 RECTAL PROLAPSE 22
376 SCAR 22
377 SKIN SWELLING 22
378 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 22
379 THROAT IRRITATION 22
380 WRONG DRUG ADMINISTERED 22
381 ADVERSE REACTION 21
382 ASPARTATE AMINOTRANSFERASE INCREASED 21
383 BONE PAIN 21
384 CATARACT 21
385 CELLULITIS 21
386 DYSPHONIA 21
387 FOLLICULITIS 21
388 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 21
389 INFLAMMATION 21
390 INJECTION SITE PRURITUS 21
391 JOINT RANGE OF MOTION DECREASED 21
392 ORTHOSTATIC HYPOTENSION 21
393 PENILE SIZE REDUCED 21
394 PRODUCT PREPARATION ERROR 21
395 SEIZURE 21
396 SLEEP APNOEA SYNDROME 21
397 THERAPY INTERRUPTED 21
398 THINKING ABNORMAL 21
399 APPLICATION SITE WARMTH 20
400 ATRIOVENTRICULAR BLOCK 20
401 BLOOD CHOLESTEROL INCREASED 20
402 DIPLOPIA 20
403 GASTRITIS 20
404 HYPOXIA 20
405 INTENTIONAL DOSE OMISSION 20
406 LAZINESS 20
407 LIVER DISORDER 20
408 MENTAL DISORDER 20
409 PAIN OF SKIN 20
410 PHOTOPHOBIA 20
411 PRURITUS GENERALISED 20
412 REBOUND ACID HYPERSECRETION 20
413 RECTAL HAEMORRHAGE 20
414 SKIN INDURATION 20
415 SKIN LESION 20
416 ARTHROPATHY 19
417 DERMATITIS ALLERGIC 19
418 INTERVERTEBRAL DISC SPACE NARROWING 19
419 KIDNEY TRANSPLANT REJECTION 19
420 LIBIDO DISORDER 19
421 LYMPHADENOPATHY 19
422 NEUTROPENIA 19
423 OSTEOPOROSIS 19
424 PANCYTOPENIA 19
425 STAPHYLOCOCCAL INFECTION 19
426 VASCULAR ANASTOMOTIC HAEMORRHAGE 19
427 VITREOUS FLOATERS 19
428 AGEUSIA 18
429 HAIR DISORDER 18
430 JOINT STIFFNESS 18
431 NEPHROLITHIASIS 18
432 OSTEOARTHRITIS 18
433 PERICARDITIS 18
434 PERITONITIS 18
435 SEBORRHOEIC DERMATITIS 18
436 SKIN HYPERTROPHY 18
437 VASCULAR COMPRESSION 18
438 APHASIA 17
439 APPLICATION SITE INFECTION 17
440 BLOOD PRESSURE SYSTOLIC INCREASED 17
441 BLOOD SODIUM DECREASED 17
442 BLOOD UREA INCREASED 17
443 CHEMICAL BURN 17
444 DRUG EFFECT INCOMPLETE 17
445 GOUT 17
446 HAEMODIALYSIS 17
447 HYPOACUSIS 17
448 IMPAIRED QUALITY OF LIFE 17
449 LABELLED DRUG-DRUG INTERACTION MEDICATION ERROR 17
450 NEOPLASM MALIGNANT 17
451 NEPHROPATHY 17
452 PAIN IN JAW 17
453 RETCHING 17
454 SKIN HYPERPIGMENTATION 17
455 VENA CAVA INJURY 17
456 WHEEZING 17
457 ATRIOVENTRICULAR BLOCK FIRST DEGREE 16
458 BLOOD GLUCOSE DECREASED 16
459 DEVICE RELATED INFECTION 16
460 DIVERTICULITIS 16
461 EAR PAIN 16
462 FEELING JITTERY 16
463 INTELLECTUAL DISABILITY 16
464 PANCREATITIS 16
465 POST PROCEDURAL COMPLICATION 16
466 PRODUCT STORAGE ERROR 16
467 SHOCK 16
468 SINUS TACHYCARDIA 16
469 THERAPY NON-RESPONDER 16
470 TRANSIENT ISCHAEMIC ATTACK 16
471 TYPE 2 DIABETES MELLITUS 16
472 VITAMIN D DECREASED 16
473 APPLICATION SITE PUSTULES 15
474 CARDIOMEGALY 15
475 CROHN^S DISEASE 15
476 DEAFNESS 15
477 DRUG ADMINISTRATION ERROR 15
478 EAR INFECTION 15
479 EMOTIONAL DISORDER 15
480 EYELID OEDEMA 15
481 HALLUCINATION 15
482 HYPERPARATHYROIDISM 15
483 HYPOKALAEMIA 15
484 INFLUENZA LIKE ILLNESS 15
485 INTRADUCTAL PAPILLARY MUCINOUS NEOPLASM 15
486 LOCALISED INFECTION 15
487 LUNG DISORDER 15
488 ORAL HERPES 15
489 PERITONITIS BACTERIAL 15
490 RENAL TRANSPLANT 15
491 RESPIRATORY DISTRESS 15
492 UNRESPONSIVE TO STIMULI 15
493 WHITE BLOOD CELL COUNT INCREASED 15
494 ACUTE CORONARY SYNDROME 14
495 BLOOD POTASSIUM DECREASED 14
496 CHOLELITHIASIS 14
497 DARK CIRCLES UNDER EYES 14
498 DISORIENTATION 14
499 DRUG INTOLERANCE 14
500 DRUG WITHDRAWAL SYNDROME 14
501 FACIAL PARALYSIS 14
502 GASTROENTERITIS 14
503 GLOMERULAR FILTRATION RATE DECREASED 14
504 HAEMATEMESIS 14
505 HEAD INJURY 14
506 HIP FRACTURE 14
507 HYPERLIPIDAEMIA 14
508 HYPONATRAEMIA 14
509 INITIAL INSOMNIA 14
510 NIGHTMARE 14
511 PERINEAL CYST 14
512 PHOTOSENSITIVITY REACTION 14
513 PRODUCT DISPENSING ERROR 14
514 PRODUCT DOSE OMISSION IN ERROR 14
515 SEMEN VOLUME DECREASED 14
516 SENSITIVE SKIN 14
517 SKIN FISSURES 14
518 TESTICULAR ATROPHY 14
519 ABASIA 13
520 ABDOMINAL WALL HAEMORRHAGE 13
521 AFFECTIVE DISORDER 13
522 APPLICATION SITE DERMATITIS 13
523 APPLICATION SITE URTICARIA 13
524 AZOTAEMIA 13
525 BODY TEMPERATURE DECREASED 13
526 CARDIOMYOPATHY 13
527 CARDIOVASCULAR DISORDER 13
528 CEREBRAL HAEMORRHAGE 13
529 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 13
530 CONJUNCTIVITIS 13
531 EAR PRURITUS 13
532 EJACULATION FAILURE 13
533 FIBROSIS 13
534 HAEMATOCHEZIA 13
535 HAEMATURIA 13
536 HEAD DISCOMFORT 13
537 HERPES ZOSTER 13
538 IMMUNODEFICIENCY 13
539 IMPAIRED GASTRIC EMPTYING 13
540 INTRAOCULAR PRESSURE INCREASED 13
541 MENINGIOMA 13
542 MIXED ANXIETY AND DEPRESSIVE DISORDER 13
543 MYOCARDIAL ISCHAEMIA 13
544 NIPPLE PAIN 13
545 OCULAR DISCOMFORT 13
546 PRODUCT ADMINISTRATION INTERRUPTED 13
547 RESPIRATORY DISORDER 13
548 RHEUMATOID ARTHRITIS 13
549 SCROTAL OEDEMA 13
550 SKIN FIBROSIS 13
551 SKIN INFECTION 13
552 SUSPECTED OFF LABEL USE 13
553 TENDONITIS 13
554 THROAT TIGHTNESS 13
555 ACUTE RESPIRATORY FAILURE 12
556 APATHY 12
557 BLOOD ALKALINE PHOSPHATASE INCREASED 12
558 CARDIAC HYPERTROPHY 12
559 COMA 12
560 DEEP VEIN THROMBOSIS 12
561 EAR DISCOMFORT 12
562 EJACULATION DISORDER 12
563 ERUCTATION 12
564 EYE DISORDER 12
565 FEELING COLD 12
566 GLAUCOMA 12
567 HAEMATOMA 12
568 HYPOTHYROIDISM 12
569 INJECTION SITE HAEMORRHAGE 12
570 INTESTINAL OBSTRUCTION 12
571 JOINT CONTRACTURE 12
572 KNEE ARTHROPLASTY 12
573 LACTIC ACIDOSIS 12
574 MALIGNANT NEOPLASM PROGRESSION 12
575 NERVOUS SYSTEM DISORDER 12
576 NEURALGIA 12
577 POOR QUALITY SLEEP 12
578 RENAL TUBULAR NECROSIS 12
579 RHABDOMYOLYSIS 12
580 THIRST 12
581 TROPONIN INCREASED 12
582 VENTRICULAR TACHYCARDIA 12
583 VIRAL INFECTION 12
584 WITHDRAWAL SYNDROME 12
585 ACCIDENTAL EXPOSURE TO PRODUCT BY CHILD 11
586 ALLERGIC REACTION TO EXCIPIENT 11
587 ALOPECIA AREATA 11
588 ANGER 11
589 ANOSMIA 11
590 BLOOD PARATHYROID HORMONE INCREASED 11
591 BLOOD PRESSURE INADEQUATELY CONTROLLED 11
592 BONE DISORDER 11
593 BREAST MASS 11
594 COLD SWEAT 11
595 COLITIS ULCERATIVE 11
596 DECREASED ACTIVITY 11
597 DEVICE ISSUE 11
598 DYSKINESIA 11
599 EXPOSURE VIA EYE CONTACT 11
600 EYE INFLAMMATION 11
601 FOETAL EXPOSURE DURING PREGNANCY 11
602 INFUSION RELATED REACTION 11
603 INTERNATIONAL NORMALISED RATIO INCREASED 11
604 LEUKOCYTOSIS 11
605 MATERNAL EXPOSURE DURING PREGNANCY 11
606 MITRAL VALVE INCOMPETENCE 11
607 MULTI-ORGAN FAILURE 11
608 NAIL DISCOLOURATION 11
609 NEPHROTIC SYNDROME 11
610 PANCREATITIS ACUTE 11
611 POLYURIA 11
612 PSORIATIC ARTHROPATHY 11
613 PSYCHOTIC DISORDER 11
614 QUALITY OF LIFE DECREASED 11
615 RESPIRATORY TRACT CONGESTION 11
616 RESPIRATORY TRACT INFECTION 11
617 ROAD TRAFFIC ACCIDENT 11
618 SENSORY DISTURBANCE 11
619 SUBDURAL HAEMATOMA 11
620 ULCER 11
621 VISUAL ACUITY REDUCED 11
622 WRONG TECHNIQUE IN DRUG USAGE PROCESS 11
623 ASPIRATION 10
624 BLOOD 25-HYDROXYCHOLECALCIFEROL DECREASED 10
625 CHORIORETINOPATHY 10
626 CHROMATURIA 10
627 COLITIS 10
628 CYSTITIS 10
629 DEPRESSED LEVEL OF CONSCIOUSNESS 10
630 EJECTION FRACTION DECREASED 10
631 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 10
632 GROIN PAIN 10
633 HEMIPARESIS 10
634 HYPERGLYCAEMIA 10
635 HYPERTENSIVE EMERGENCY 10
636 IMPAIRED WORK ABILITY 10
637 INJECTION SITE RASH 10
638 IRRITABLE BOWEL SYNDROME 10
639 LIMB DISCOMFORT 10
640 MADAROSIS 10
641 MELAENA 10
642 MUSCLE TWITCHING 10
643 OCULAR HYPERTENSION 10
644 OSTEOPENIA 10
645 PNEUMONIA HAEMOPHILUS 10
646 POST 5-ALPHA-REDUCTASE INHIBITOR SYNDROME 10
647 PRODUCT ADHESION ISSUE 10
648 PRODUCT ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 10
649 PRODUCT COMPLAINT 10
650 PRODUCT DOSE OMISSION 10
651 RESPIRATORY ARREST 10
652 SKIN PLAQUE 10
653 SKIN TEXTURE ABNORMAL 10
654 SOCIAL AVOIDANT BEHAVIOUR 10
655 STEVENS-JOHNSON SYNDROME 10
656 SYSTEMIC LUPUS ERYTHEMATOSUS 10
657 THERAPY PARTIAL RESPONDER 10
658 THERMAL BURN 10
659 URINARY RETENTION 10
660 VANISHING BILE DUCT SYNDROME 10
661 VITAMIN D DEFICIENCY 10
662 WOUND 10
663 ABDOMINAL PAIN LOWER 9
664 APPLICATION SITE EROSION 9
665 APPLICATION SITE INJURY 9
666 APPLICATION SITE SCAR 9
667 ARTERIOSCLEROSIS CORONARY ARTERY 9
668 ATRIAL FLUTTER 9
669 BLOOD GLUCOSE ABNORMAL 9
670 BLOOD IRON DECREASED 9
671 BLOOD PHOSPHORUS INCREASED 9
672 BREAST CANCER 9
673 BREAST PAIN 9
674 BREAST TENDERNESS 9
675 CARDIAC MURMUR 9
676 COAGULOPATHY 9
677 DEAFNESS UNILATERAL 9
678 DISTRIBUTIVE SHOCK 9
679 EOSINOPHILIA 9
680 EPSTEIN-BARR VIRUS INFECTION 9
681 EYE DISCHARGE 9
682 EYELID PTOSIS 9
683 FACIAL PAIN 9
684 FEEDING DISORDER 9
685 FORMICATION 9
686 GAMMA-GLUTAMYLTRANSFERASE INCREASED 9
687 GENITAL HYPOAESTHESIA 9
688 HEPATIC FAILURE 9
689 HIATUS HERNIA 9
690 HYPERSOMNIA 9
691 INJECTION SITE URTICARIA 9
692 INTENTIONAL DRUG MISUSE 9
693 ISCHAEMIC STROKE 9
694 JAUNDICE 9
695 LEUKOPENIA 9
696 MIDDLE INSOMNIA 9
697 MUSCLE ATROPHY 9
698 NERVE INJURY 9
699 NOCTURIA 9
700 OBESITY 9
701 PANIC REACTION 9
702 POOR QUALITY PRODUCT ADMINISTERED 9
703 PORTAL VEIN THROMBOSIS 9
704 PROSTATE CANCER 9
705 PSYCHIATRIC SYMPTOM 9
706 ROSACEA 9
707 SEASONAL ALLERGY 9
708 SECRETION DISCHARGE 9
709 SEPTIC SHOCK 9
710 SINUS DISORDER 9
711 SKIN SENSITISATION 9
712 SLUGGISHNESS 9
713 TACHYPNOEA 9
714 TASTE DISORDER 9
715 THYROID DISORDER 9
716 URINE OUTPUT DECREASED 9
717 WRONG PRODUCT ADMINISTERED 9
718 ABNORMAL BEHAVIOUR 8
719 ACTIVITIES OF DAILY LIVING IMPAIRED 8
720 ANDROGENETIC ALOPECIA 8
721 ANGIONEUROTIC OEDEMA 8
722 APPLICATION SITE HYPOAESTHESIA 8
723 APPLICATION SITE WOUND 8
724 BICYTOPENIA 8
725 BLOOD TRIGLYCERIDES INCREASED 8
726 BLOOD URINE PRESENT 8
727 BOWEL MOVEMENT IRREGULARITY 8
728 CORONARY ARTERY OCCLUSION 8
729 CRYING 8
730 DEMENTIA 8
731 DEPERSONALISATION/DEREALISATION DISORDER 8
732 DERMAL CYST 8
733 DIABETIC NEUROPATHY 8
734 EATING DISORDER 8
735 ELECTROCARDIOGRAM ABNORMAL 8
736 ELECTROCARDIOGRAM T WAVE INVERSION 8
737 ENTEROCOCCAL INFECTION 8
738 FAECES DISCOLOURED 8
739 FREQUENT BOWEL MOVEMENTS 8
740 GAIT INABILITY 8
741 GASTROENTERITIS VIRAL 8
742 GLOMERULONEPHRITIS 8
743 HAEMORRHAGIC STROKE 8
744 HEART RATE DECREASED 8
745 HEPATITIS 8
746 HERNIA 8
747 HORMONE LEVEL ABNORMAL 8
748 IMPAIRED HEALING 8
749 INTERSTITIAL LUNG DISEASE 8
750 LOCAL SWELLING 8
751 LOWER LIMB FRACTURE 8
752 LUNG INFILTRATION 8
753 MELANOCYTIC NAEVUS 8
754 METHAEMOGLOBINAEMIA 8
755 MUSCLE DISORDER 8
756 MUSCLE TIGHTNESS 8
757 MUSCULOSKELETAL DISCOMFORT 8
758 MYOCARDITIS 8
759 NEPHROPATHY TOXIC 8
760 NEURODERMATITIS 8
761 ORAL DISORDER 8
762 PHARMACEUTICAL PRODUCT COMPLAINT 8
763 POST PROCEDURAL INFECTION 8
764 PROCEDURAL PAIN 8
765 PRODUCT PHYSICAL ISSUE 8
766 PRODUCT PRESCRIBING ISSUE 8
767 PROSTATIC SPECIFIC ANTIGEN INCREASED 8
768 RENAL TRANSPLANT FAILURE 8
769 RIB FRACTURE 8
770 SINUS BRADYCARDIA 8
771 SUICIDAL BEHAVIOUR 8
772 THERAPEUTIC RESPONSE SHORTENED 8
773 TOOTH FRACTURE 8
774 TOXIC EPIDERMAL NECROLYSIS 8
775 UMBILICAL HERNIA 8
776 URINARY INCONTINENCE 8
777 VAGINAL HAEMORRHAGE 8
778 VENTRICULAR EXTRASYSTOLES 8
779 VENTRICULAR HYPERTROPHY 8
780 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 8
781 ABORTION INDUCED 7
782 ALOPECIA UNIVERSALIS 7
783 ALTERED STATE OF CONSCIOUSNESS 7
784 AMENORRHOEA 7
785 APPLICATION SITE FOLLICULITIS 7
786 ARTERIOVENOUS FISTULA 7
787 ASTHENOPIA 7
788 BLOOD CREATINE PHOSPHOKINASE INCREASED 7
789 BODY TEMPERATURE INCREASED 7
790 CYST 7
791 DENTAL CARIES 7
792 DEVICE MALFUNCTION 7
793 DIABETIC KETOACIDOSIS 7
794 DIZZINESS POSTURAL 7
795 DRUG ADMINISTERED IN WRONG DEVICE 7
796 DRUG PRESCRIBING ERROR 7
797 DRUG RESISTANCE 7
798 DRY THROAT 7
799 ENCEPHALOPATHY 7
800 ESSENTIAL HYPERTENSION 7
801 FEMUR FRACTURE 7
802 GASTRIC DISORDER 7
803 GASTRIC ULCER 7
804 GASTROINTESTINAL PAIN 7
805 GENITAL DISORDER 7
806 GLOMERULONEPHRITIS ACUTE 7
807 GLOSSODYNIA 7
808 GLUCOSE TOLERANCE IMPAIRED 7
809 HAEMOGLOBIN ABNORMAL 7
810 HALLUCINATION, VISUAL 7
811 HYPERPHOSPHATAEMIA 7
812 HYPOCALCAEMIA 7
813 HYPOTONIA 7
814 INCREASED APPETITE 7
815 INGROWN HAIR 7
816 INSURANCE ISSUE 7
817 INTERNAL HAEMORRHAGE 7
818 INTERVERTEBRAL DISC PROTRUSION 7
819 IRON DEFICIENCY ANAEMIA 7
820 JOINT INJURY 7
821 LICHEN PLANOPILARIS 7
822 LIGAMENT SPRAIN 7
823 MALIGNANT HYPERTENSION 7
824 MALNUTRITION 7
825 MENTAL FATIGUE 7
826 MICTURITION URGENCY 7
827 MULTIPLE ORGAN DYSFUNCTION SYNDROME 7
828 MUSCULAR DYSTROPHY 7
829 MYOSITIS 7
830 NASAL DISCOMFORT 7
831 NEOPLASM PROGRESSION 7
832 NODULE 7
833 OESOPHAGITIS 7
834 OSTEOMYELITIS 7
835 PANCREATIC CYSTADENOMA 7
836 PELVIC FRACTURE 7
837 PERIPHERAL VASCULAR DISORDER 7
838 PHARYNGEAL OEDEMA 7
839 PHOTOPSIA 7
840 PLATELET COUNT INCREASED 7
841 PLEUROPERICARDITIS 7
842 PRODUCT AVAILABILITY ISSUE 7
843 PRODUCT LABEL ON WRONG PRODUCT 7
844 PRODUCT PREPARATION ISSUE 7
845 PRODUCT RESIDUE PRESENT 7
846 PRODUCT TASTE ABNORMAL 7
847 RENAL CANCER 7
848 RENAL PAIN 7
849 RETINAL DETACHMENT 7
850 SARS-COV-2 ANTIBODY TEST POSITIVE 7
851 SKIN ATROPHY 7
852 SUBARACHNOID HAEMORRHAGE 7
853 TEARFULNESS 7
854 TEMPERATURE INTOLERANCE 7
855 TENDON PAIN 7
856 THROMBOSIS IN DEVICE 7
857 TOOTH LOSS 7
858 TRICUSPID VALVE INCOMPETENCE 7
859 TYPE 1 DIABETES MELLITUS 7
860 VENOUS THROMBOSIS 7
861 ABDOMINAL TENDERNESS 6
862 ABSCESS 6
863 ACUTE PULMONARY OEDEMA 6
864 ADRENAL INSUFFICIENCY 6
865 ANAL CYST 6
866 ANAL INCONTINENCE 6
867 ANKLE FRACTURE 6
868 ANOREXIA 6
869 ANTI-NEUTROPHIL CYTOPLASMIC ANTIBODY POSITIVE VASCULITIS 6
870 APPETITE DISORDER 6
871 APPLICATION SITE ECZEMA 6
872 APPLICATION SITE FISSURE 6
873 APPLICATION SITE PLAQUE 6
874 ATRIOVENTRICULAR BLOCK COMPLETE 6
875 BACTERAEMIA 6
876 BACTERIAL INFECTION 6
877 BLOOD CREATINE INCREASED 6
878 BLOOD OESTROGEN INCREASED 6
879 BLOOD TEST ABNORMAL 6
880 BONE DENSITY DECREASED 6
881 BRAIN NATRIURETIC PEPTIDE INCREASED 6
882 BREAST ENLARGEMENT 6
883 CARDIAC FLUTTER 6
884 CHOKING 6
885 CONCUSSION 6
886 CONJUNCTIVAL HAEMORRHAGE 6
887 DIABETIC RETINOPATHY 6
888 DRUG ABUSE 6
889 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 6
890 DYSPHEMIA 6
891 DYSSTASIA 6
892 ELECTROCARDIOGRAM QT PROLONGED 6
893 ENDOCARDITIS 6
894 EPILEPSY 6
895 EUPHORIC MOOD 6
896 EXTREMITY CONTRACTURE 6
897 FEAR OF DEATH 6
898 FEBRILE NEUTROPENIA 6
899 FLANK PAIN 6
900 FOREIGN BODY SENSATION IN EYES 6
901 FURUNCLE 6
902 HAEMOLYSIS 6
903 HAEMOPTYSIS 6
904 HEPATIC FUNCTION ABNORMAL 6
905 HIRSUTISM 6
906 HYPERPHAGIA 6
907 HYPERTENSIVE ENCEPHALOPATHY 6
908 HYPERTENSIVE NEPHROPATHY 6
909 HYPERTHYROIDISM 6
910 HYPERVOLAEMIA 6
911 HYPOAESTHESIA ORAL 6
912 ILL-DEFINED DISORDER 6
913 INCORRECT ROUTE OF DRUG ADMINISTRATION 6
914 INJECTION SITE ALOPECIA 6
915 INJECTION SITE REACTION 6
916 INTERVERTEBRAL DISC DEGENERATION 6
917 IRON DEFICIENCY 6
918 KIDNEY INFECTION 6
919 LANGERHANS^ CELL HISTIOCYTOSIS 6
920 LIMB INJURY 6
921 LIVER INJURY 6
922 MASS 6
923 MEIBOMIAN GLAND DYSFUNCTION 6
924 MULTIPLE FRACTURES 6
925 MYOCARDIAL NECROSIS 6
926 NEOPLASM 6
927 NEUROLOGICAL SYMPTOM 6
928 NONSPECIFIC REACTION 6
929 PAINFUL EJACULATION 6
930 PALLOR 6
931 PARAESTHESIA ORAL 6
932 PAROSMIA 6
933 PERITONEAL DIALYSIS COMPLICATION 6
934 PHARYNGEAL SWELLING 6
935 PIGMENTATION DISORDER 6
936 PNEUMONIA ASPIRATION 6
937 PNEUMONIA FUNGAL 6
938 POSTOPERATIVE WOUND INFECTION 6
939 PRODUCT CONTAINER ISSUE 6
940 PULMONARY CONGESTION 6
941 RASH GENERALISED 6
942 RASH VESICULAR 6
943 REFUSAL OF TREATMENT BY PATIENT 6
944 SKIN HAEMORRHAGE 6
945 SKIN ODOUR ABNORMAL 6
946 SKIN PAPILLOMA 6
947 SKIN TEST POSITIVE 6
948 SKIN WEEPING 6
949 STRESS CARDIOMYOPATHY 6
950 THERAPY CHANGE 6
951 THROMBOTIC MICROANGIOPATHY 6
952 TOOTH DISORDER 6
953 TRANSAMINASES INCREASED 6
954 UPPER-AIRWAY COUGH SYNDROME 6
955 URINE ANALYSIS ABNORMAL 6
956 UROSEPSIS 6
957 ABNORMAL WEIGHT GAIN 5
958 ABSCESS INTESTINAL 5
959 ACROCHORDON 5
960 ALLODYNIA 5
961 ANAPHYLACTIC REACTION 5
962 ANGINA UNSTABLE 5
963 ANORGASMIA 5
964 ANURIA 5
965 AORTIC ANEURYSM 5
966 APLASIA PURE RED CELL 5
967 APPLICATION SITE NODULE 5
968 ATELECTASIS 5
969 AURICULAR SWELLING 5
970 AUTOIMMUNE DISORDER 5
971 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5
972 BLINDNESS TRANSIENT 5
973 BLINDNESS UNILATERAL 5
974 BLOOD ALBUMIN DECREASED 5
975 BLOOD BILIRUBIN INCREASED 5
976 BLOOD MAGNESIUM DECREASED 5
977 BLOOD URIC ACID INCREASED 5
978 CANDIDA INFECTION 5
979 CARDIOGENIC SHOCK 5
980 CAROTID ARTERY OCCLUSION 5
981 CARPAL TUNNEL SYNDROME 5
982 CHEMICAL BURN OF SKIN 5
983 CHOLECYSTITIS 5
984 COLLAGEN DISORDER 5
985 CONGESTIVE CARDIOMYOPATHY 5
986 CORONARY ARTERY BYPASS 5
987 DECUBITUS ULCER 5
988 DELIRIUM 5
989 DEMENTIA ALZHEIMER^S TYPE 5
990 DEVICE DELIVERY SYSTEM ISSUE 5
991 DEVICE RELATED SEPSIS 5
992 DEVICE USE ERROR 5
993 DEVICE USE ISSUE 5
994 DIASTOLIC DYSFUNCTION 5
995 DISABILITY 5
996 DISCOURAGEMENT 5
997 DRUG DOSE OMISSION BY DEVICE 5
998 DRUG EXPOSURE DURING PREGNANCY 5
999 EPIDIDYMITIS 5